168 related articles for article (PubMed ID: 15806426)
1. Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects.
Wennerholm A; Allqvist A; Svensson JO; Gustafsson LL; Mirghani RA; Bertilsson L
Eur J Clin Pharmacol; 2005 Apr; 61(2):113-8. PubMed ID: 15806426
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of alprazolam, 4- and alpha-hydroxyalprazolam in plasma samples using liquid chromatography mass spectrometry.
Allqvist A; Wennerholm A; Svensson JO; Mirghani RA
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(1):127-31. PubMed ID: 15607716
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.
Molanaei H; Stenvinkel P; Qureshi AR; Carrero JJ; Heimbürger O; Lindholm B; Diczfalusy U; Odar-Cederlöf I; Bertilsson L
Eur J Clin Pharmacol; 2012 May; 68(5):571-7. PubMed ID: 22159869
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationship.
Wright CE; Sisson TL; Fleishaker JC; Antal EJ
J Clin Pharmacol; 1997 Apr; 37(4):321-9. PubMed ID: 9115058
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between single-oral dose kinetics of alprazolam and cytochrome P4503A and cytochrome P4502C19].
Yasui N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):109-12. PubMed ID: 8905799
[TBL] [Abstract][Full Text] [Related]
6. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Masica AL; Mayo G; Wilkinson GR
Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
[TBL] [Abstract][Full Text] [Related]
7. Alprazolam-ritonavir interaction: implications for product labeling.
Greenblatt DJ; von Moltke LL; Harmatz JS; Durol AL; Daily JP; Graf JA; Mertzanis P; Hoffman JL; Shader RI
Clin Pharmacol Ther; 2000 Apr; 67(4):335-41. PubMed ID: 10801241
[TBL] [Abstract][Full Text] [Related]
8. No correlations between the urinary ratio of 6beta-hydroxycortisol to free cortisol and pharmacokinetics of alprazolam.
Yasui-Furukori N; Kondo T; Kubota T; Otake H; Ohkubo T; Nagasaki T; Sugawara K; Chiba K; Otani K; Kaneko S
Eur J Clin Pharmacol; 2001 Jul; 57(4):285-8. PubMed ID: 11549205
[TBL] [Abstract][Full Text] [Related]
9. Determination of alprazolam and alpha-hydroxyalprazolam in human plasma by gas chromatography/negative-ion chemical ionization mass spectrometry.
Höld KM; Crouch DJ; Rollins DE; Wilkins DG; Canfield DV; Maes RA
J Mass Spectrom; 1996 Sep; 31(9):1033-8. PubMed ID: 8831153
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers.
Allqvist A; Miura J; Bertilsson L; Mirghani RA
Eur J Clin Pharmacol; 2007 Feb; 63(2):173-9. PubMed ID: 17200836
[TBL] [Abstract][Full Text] [Related]
12. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers.
Glue P; Fang A; Gandelman K; Klee B
Am J Ther; 2006; 13(5):418-22. PubMed ID: 16988537
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and physiologic effects of alprazolam after a single oral dose in healthy mares.
Wong DM; Davis JL; Alcott CJ; Hepworth-Warren KL; Galow-Kersh NL; Rice S; Coetzee JF
J Vet Pharmacol Ther; 2015 Jun; 38(3):301-4. PubMed ID: 25427652
[TBL] [Abstract][Full Text] [Related]
15. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam.
Otani K; Yasui N; Furukori H; Kaneko S; Tasaki H; Ohkubo T; Nagasaki T; Sugawara K; Hayashi K
Int Clin Psychopharmacol; 1997 May; 12(3):153-7. PubMed ID: 9248872
[TBL] [Abstract][Full Text] [Related]
16. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
Markowitz JS; Donovan JL; Devane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
[TBL] [Abstract][Full Text] [Related]
17. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects.
Park JY; Kim KA; Park PW; Lee OJ; Kang DK; Shon JH; Liu KH; Shin JG
Clin Pharmacol Ther; 2006 Jun; 79(6):590-9. PubMed ID: 16765147
[TBL] [Abstract][Full Text] [Related]
18. Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam.
Drabant S; Tóth M; Bereczki A; Bajnógel J; Tömlö J; Klebovich I
Eur J Clin Pharmacol; 2006 Jul; 62(7):587-8. PubMed ID: 16791582
[No Abstract] [Full Text] [Related]
19. Effect of venlafaxine on the pharmacokinetics of alprazolam.
Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
Psychopharmacol Bull; 1998; 34(2):211-9. PubMed ID: 9641003
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of alprazolam and alpha-hydroxyalprazolam in human plasma using liquid chromatography electrospray ionization MS-MS.
Crouch DJ; Rollins DE; Canfield DV; Andrenyak DM; Schulties JE
J Anal Toxicol; 1999 Oct; 23(6):479-85. PubMed ID: 10517554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
